Dr. Marcus Reid

Dr. Marcus Reid holds an MSc in Health Sciences and has spent 12 years writing about evidence-based medicine, clinical pharmacology, and mental health treatment. His work focuses on translating complex medical research into practical guidance for patients and caregivers. He has covered GLP-1 receptor agonists, metabolic medications, and weight management interventions since the first FDA approvals of semaglutide-class drugs in 2017. All YMYL content on DL Method is reviewed against current clinical guidelines before publication.